BeiGene, Ltd. Capital Reinvestment Ratio
BeiGene, Ltd. capital reinvestment ratio. BeiGene, Ltd. (ONC) has a Capital Reinvestment Ratio of 0.20x as of March 2026, meaning it reinvests 0% of its operating cash flow ($201.94 Million) in capital expenditures ($40.91 Million). Check BeiGene, Ltd. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of BeiGene, Ltd. (2013–2025)
Capital reinvestment ratio of BeiGene, Ltd. from 2013 to 2025. This chart tracks BeiGene, Ltd.'s Capital Reinvestment Ratio across 3 annual periods. Also explore BeiGene, Ltd. (ONC) net asset momentum to track the company's year-over-year net asset growth rate.
BeiGene, Ltd. Capital Reinvestment Ratio by Year (2013–2025)
BeiGene, Ltd. capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see BeiGene, Ltd. cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | $1.13 Billion | $185.84 Million | ▼ -96.4% |
| 2017 | 4.61x | $12.75 Million | $58.73 Million | ▲ +7005.2% |
| 2013 | 0.06x | $4.07 Million | $264.00K | — |